Erratum: Author correction to "YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer" Acta Pharmaceutica Sinica B 12 (2022) 2845-2858
Acta Pharmaceutica Sinica B
; (6): 3178-3179, 2023.
Article
in En
| WPRIM
| ID: wpr-982895
Responsible library:
WPRO
ABSTRACT
[This corrects the article DOI 10.1016/j.apsb.2022.02.031.].
Full text:
1
Database:
WPRIM
Language:
En
Journal:
Acta Pharmaceutica Sinica B
Year:
2023
Document type:
Article